COVID-19 and diabetes cutaneous comorbidity
Diabetes patients have a higher risk in morbidity and mortality with COVID-19.It should be considered as a risk factor for a rapid progression and bad prognosis of COVID-19.Additional, the research in the cutaneous complication of diabetes with COVID-19 need to be considered. Therefore, particular c...
Main Authors: | Minchen Zhang, Weicheng Gao |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-09-01
|
Series: | Metabolism Open |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589936820300359 |
Similar Items
-
Comorbidities and COVID-19
by: Lakshmi Narayana Yaddanapudi
Published: (2020-01-01) -
Management of COVID-19 in comorbidities
by: Chiara Cardamone, et al.
Published: (2020-12-01) -
COVID-19 and cardiovascular comorbidities: An update
by: Rogério Teixeira, et al.
Published: (2020-08-01) -
COVID-19 and cardiovascular comorbidities: An update
by: Rogério Teixeira, et al.
Published: (2020-08-01) -
Covid-19 in the Elderly and Patient with Comorbidity
by: J. Minooeifar
Published: (2020-11-01)